Literature DB >> 35102379

Combination of dynapenia and abdominal obesity affects long-term physical performance trajectories in older adults: sex differences.

Roberta de Oliveira Máximo1, Dayane Capra de Oliveira1, Paula Camila Ramirez1, Mariane Marques Luiz1, Aline Fernanda de Souza1, Maicon Luís Bicigo Delinocente2, Andrew Steptoe3, Cesar de Oliveira3, Tiago da Silva Alexandre1,2,3,4.   

Abstract

BACKGROUND: There is little epidemiological evidence of sex differences in the association between dynapenic abdominal obesity and the decline in physical performance in older adults.
OBJECTIVES: The aims of the present study were to investigate whether the decline in physical performance is worse in individuals with dynapenic abdominal obesity and whether there are sex differences in this association.
METHODS: Of 6183 individuals aged ≥60 y from the English Longitudinal Study of Ageing, 2308 participants with missing data were excluded. Therefore, a longitudinal analysis was conducted with 3875 older adults. Abdominal obesity was determined based on waist circumference (>102 cm for males, and >88 cm for females), and dynapenia was based on grip strength (<26 kg for males, <16 kg for female). The sample was divided into 4 groups: nondynapenic/nonabdominal obesity (ND/NAO), nondynapenic/abdominal obesity (ND/AO), dynapenic/nonabdominal obesity (D/NAO), and dynapenic/abdominal obesity (D/AO). Decline in physical performance in an 8-y follow-up period was analyzed using generalized linear mixed models.
RESULTS: At baseline, both male (-1.11 points; 95% CI: -1.58, -0.65 points; P < 0.001) and female (-1.39 points; 95% CI: -1.76, -1.02 points; P < 0.001) with D/AO had worse performances on the Short Physical Performance Battery (SPPB) than their counterparts in the ND/NAO group. Over the 8-y follow-up, males with D/AO had a faster rate of decline in the SPPB performance compared with males in the ND/NAO group (-0.11 points/y; 95% CI: -0.21, -0.01 points; P = 0.03).
CONCLUSIONS: D/AO is associated with a stronger decline in physical performance in males but not in females. The identification and management of dynapenic abdominal obesity could be essential to avoiding the first signs of functional impairment in older males.
© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.

Entities:  

Keywords:  SPPB; grip strength; physical performance; trajectories; waist circumference

Mesh:

Year:  2022        PMID: 35102379      PMCID: PMC9071386          DOI: 10.1093/ajcn/nqac023

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   8.472


  40 in total

1.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

2.  A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission.

Authors:  J M Guralnik; E M Simonsick; L Ferrucci; R J Glynn; L F Berkman; D G Blazer; P A Scherr; R B Wallace
Journal:  J Gerontol       Date:  1994-03

3.  Cohort profile: the English longitudinal study of ageing.

Authors:  Andrew Steptoe; Elizabeth Breeze; James Banks; James Nazroo
Journal:  Int J Epidemiol       Date:  2012-11-09       Impact factor: 7.196

4.  Common health predictors of early retirement: findings from the English Longitudinal Study of Ageing.

Authors:  Neil E Rice; Iain A Lang; William Henley; David Melzer
Journal:  Age Ageing       Date:  2011-01       Impact factor: 10.668

5.  The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study.

Authors:  Bret H Goodpaster; Seok Won Park; Tamara B Harris; Steven B Kritchevsky; Michael Nevitt; Ann V Schwartz; Eleanor M Simonsick; Frances A Tylavsky; Marjolein Visser; Anne B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-10       Impact factor: 6.053

6.  Accuracy of body mass index in diagnosing obesity in the adult general population.

Authors:  A Romero-Corral; V K Somers; J Sierra-Johnson; R J Thomas; M L Collazo-Clavell; J Korinek; T G Allison; J A Batsis; F H Sert-Kuniyoshi; F Lopez-Jimenez
Journal:  Int J Obes (Lond)       Date:  2008-02-19       Impact factor: 5.095

7.  Use of the Short Physical Performance Battery Score to predict loss of ability to walk 400 meters: analysis from the InCHIANTI study.

Authors:  Sarinnapha Vasunilashorn; Antonia K Coppin; Kushang V Patel; Fulvio Lauretani; Luigi Ferrucci; Stefania Bandinelli; Jack M Guralnik
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-31       Impact factor: 6.053

8.  Added value of physical performance measures in predicting adverse health-related events: results from the Health, Aging And Body Composition Study.

Authors:  Matteo Cesari; Stephen B Kritchevsky; Anne B Newman; Eleanor M Simonsick; Tamara B Harris; Brenda W Penninx; Jennifer S Brach; Frances A Tylavsky; Suzanne Satterfield; Doug C Bauer; Susan M Rubin; Marjolein Visser; Marco Pahor
Journal:  J Am Geriatr Soc       Date:  2009-02       Impact factor: 5.562

9.  The combination of dynapenia and abdominal obesity as a risk factor for worse trajectories of IADL disability among older adults.

Authors:  Tiago da Silva Alexandre; Shaun Scholes; Jair Licio Ferreira Santos; Yeda Aparecida de Oliveira Duarte; Cesar de Oliveira
Journal:  Clin Nutr       Date:  2017-10-02       Impact factor: 7.324

10.  Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project.

Authors:  Robert R McLean; Michelle D Shardell; Dawn E Alley; Peggy M Cawthon; Maren S Fragala; Tamara B Harris; Anne M Kenny; Katherine W Peters; Luigi Ferrucci; Jack M Guralnik; Stephen B Kritchevsky; Douglas P Kiel; Maria T Vassileva; Qian-Li Xue; Subashan Perera; Stephanie A Studenski; Thuy-Tien L Dam
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.